AI Article Synopsis
- Less than 0.5% of patients with inflammatory bowel disease or rheumatoid arthritis developed an invasive fungal infection (IFI) within a year of starting TNF-alpha therapy.
- Histoplasmosis was identified as the most frequently occurring type of IFI among these patients.
- The incidence of IFIs varied depending on factors like geographic region, existing health conditions, and the use of specific immunosuppressive drugs.
Article Abstract
In a commercial claims database analysis, <0.5% of patients with inflammatory bowel disease or rheumatoid arthritis developed an IFI within one year of initiating TNF-alpha therapy. Histoplasmosis was the most common IFI type. Overall IFI incidence varied based on region, underlying conditions, and use of certain immunosuppressive medications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/cid/ciae444 | DOI Listing |
Publication Analysis
Top Keywords
incidence risk
4
risk factors
4
factors invasive
4
invasive fungal
4
fungal infections
4
infections patients
4
patients initiating
4
initiating tnf-alpha
4
tnf-alpha inhibitors
4
inhibitors inflammatory
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!